https://www.europeanpharmaceuticalreview.com/logged-in-expired-subscriber-fallback/1.article 2026-03-03T16:31:18.480Z https://www.europeanpharmaceuticalreview.com/logged-in-not-a-subscriber-fallback/2.article 2026-03-03T16:31:18.480Z https://www.europeanpharmaceuticalreview.com/lead-generation-eme-access-message/17.article 2026-06-03T12:03:41.277Z https://www.europeanpharmaceuticalreview.com/logged-out-register-for-access-fallback/27.article 2026-03-24T10:39:52.593Z https://www.europeanpharmaceuticalreview.com/logged-in-premium-content-no-access/28.article 2026-03-24T10:40:28.423Z https://www.europeanpharmaceuticalreview.com/news/novel-nmr-based-method-could-facilitate-safer-api-manufacturing/268274.article 2026-04-24T15:05:38.477Z https://www.europeanpharmaceuticalreview.com/news/fujifilms-lars-petersen-on-trust-based-partnerships-and-a-people-first-culture/269189.article 2026-04-16T14:59:49.823Z https://www.europeanpharmaceuticalreview.com/webinars/complying-with-usp-chapters-41-and-1251-revisions-for-pharma-quality-control/269345.article 2026-05-11T11:19:16.670Z https://www.europeanpharmaceuticalreview.com/webinars/harnessing-digital-pcr-for-rapid-sterility-testing/269429.article 2026-05-11T13:30:22.810Z https://www.europeanpharmaceuticalreview.com/webinars/practical-considerations-for-aseptic-gowning-in-contamination-control-strategies/269466.article 2026-05-11T11:15:50.760Z https://www.europeanpharmaceuticalreview.com/reithera-on-vaccines-and-remaining-nimble-around-emerging-threats/269492.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/webinars/harnessing-ai-for-more-efficient-clinical-trials/269904.article 2026-06-05T16:02:17.157Z https://www.europeanpharmaceuticalreview.com/news/generic-manufacturer-safety-records-revealed-by-new-consumer-app/269922.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/samsung-gains-first-us-manufacturing-site-through-280m-gsk-deal/269936.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/us-oral-glp-1-first-as-novo-nordisk-launches-wegovy-pill/269956.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/endotoxin-testing-milestone-reached-with-european-pharmacopoeias-animal-shift/269970.article 2026-06-11T14:45:55.953Z https://www.europeanpharmaceuticalreview.com/news/amgen-acquires-uk-cancer-biotech-dark-blue-therapeutics-for-840m/269979.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chemical-assessment-in-europe-to-be-streamlined-under-new-legislation/270001.article 2026-06-11T14:45:55.953Z https://www.europeanpharmaceuticalreview.com/news/lilly-acquires-inflammatory-firm-ventyx-biosciences-for-12bn-deal/270008.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/how-to-navigate-expedited-review-pathways-a-guide-for-biopharma-companies/270016.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/quotient-sciences/270017.article 2026-03-05T12:58:51.503Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-hires-rick-suarez-to-lead-its-biopharma-efforts-in-the-us/270051.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/endotoxins-research-supports-recombinant-reagent-use-for-pharma-qc/270058.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novartis-to-site-its-fourth-us-radioligand-manufacturing-facility-in-florida/270100.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sanofi-wins-eu-approval-for-its-type-1-diabetes-biologic-teizeild/270107.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/european-pharmacopoeia-publishes-new-data-quality-framework/270143.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sentynl-secures-us-first-approval-for-rare-menkes-disease/270151.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ai-framework-could-enhance-continuous-manufacturing-say-fda-researchers/270194.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/proven-strategies-for-cleanroom-and-water-system-qualification-success/270201.article 2026-03-31T21:47:16.310Z https://www.europeanpharmaceuticalreview.com/news/abbvie-licenses-novel-bispecific-antibody-from-remegen-for-5bn/270207.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/a-softwaresupported-aiassisted-workflow-for-optimising-lc-gradient-methods/270247.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/ema-and-fda-issue-joint-ai-guidance-for-medicine-development/270259.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/polymer-capsule-drug-delivery-innovation-demonstrates-sustainability-promise/270279.article 2026-05-06T08:48:56.557Z https://www.europeanpharmaceuticalreview.com/news/automation-joins-ai-and-cybersecurity-as-digital-priorities-for-indian-pharma/270281.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/tevas-migraine-biologic-ajovy-marks-phase-iii-progress-for-paediatric-patients/270325.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/yeast-research-could-advance-sustainable-pharmaceutical-bioproduction/270428.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/johnson-and-johnsons-caplyta-demonstrates-phase-iii-promise-for-depression/270451.article 2026-06-11T14:45:55.953Z https://www.europeanpharmaceuticalreview.com/news/kincell-bio-promotes-bruce-thompson-to-president-and-chief-technology-officer/270466.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/eu-concludes-major-free-trade-agreement-with-mercosur-countries/270501.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/gaelic-labs-pharma-is-increasingly-focused-on-supply-chain-security/270507.article 2026-04-28T13:16:34.027Z https://www.europeanpharmaceuticalreview.com/news/biomanufacturing-framework-could-boost-microbial-production-efficiency/270524.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gsk-acquires-food-allergy-firm-rapt-therapeutics-for-22bn/270554.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/europe-marks-key-milestone-in-adopting-critical-medicines-act/270566.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/home/premium-members-qualification/542347.article 2026-03-09T08:23:50.437Z https://www.europeanpharmaceuticalreview.com/terms-and-conditions/853546.article 2026-03-26T14:56:37.603Z https://www.europeanpharmaceuticalreview.com/about-us/miriam-guest/853547.article 2026-03-27T16:29:55.937Z https://www.europeanpharmaceuticalreview.com/about-us/jo-pisani/853548.article 2026-03-27T16:29:55.937Z https://www.europeanpharmaceuticalreview.com/about-us/dr-paul-g-royall/853549.article 2026-03-27T16:29:55.937Z https://www.europeanpharmaceuticalreview.com/about-us/dr-steven-baertschi/853550.article 2026-03-30T14:36:19.097Z https://www.europeanpharmaceuticalreview.com/about-us/dr-david-p-elder/853551.article 2026-03-27T16:29:55.937Z https://www.europeanpharmaceuticalreview.com/about-us/michael-miller/853552.article 2026-03-27T16:29:55.937Z https://www.europeanpharmaceuticalreview.com/about-us/don-clark/853553.article 2026-03-27T16:29:55.937Z https://www.europeanpharmaceuticalreview.com/about-us/matthew-moran/853554.article 2026-03-27T16:29:55.937Z https://www.europeanpharmaceuticalreview.com/about-us/dr-sheraz-gul/853555.article 2026-03-27T16:29:55.937Z https://www.europeanpharmaceuticalreview.com/advertising-opportunities/european-pharmaceutical-review-media-and-content-planner-2026/853572.article 2026-04-09T16:49:43.883Z https://www.europeanpharmaceuticalreview.com/webinars/the-either-or-trap-consequences-of-enhanced-mechanical-calibration-vs-fully-qualifying-your-dissolution-equipment/853574.article 2026-06-05T20:02:46.477Z https://www.europeanpharmaceuticalreview.com/webinars/how-thermal-analysis-can-enhance-pharmaceutical-drug-development/853575.article 2026-06-05T12:16:55.420Z https://www.europeanpharmaceuticalreview.com/news/genentech-doubles-investment-in-north-carolina-manufacturing-facility/1130590.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/moderna-merck-and-co-cancer-vaccine-with-keytruda-shows-late-stage-promise/1130597.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/hoth-therapeutics-topical-therapy-shines-in-cancer-toxicity-trial/1130616.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/advanced-manufacturing-research-supports-automated-production-of-critical-api/1130630.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/wuxi-biologics-partners-with-hanchorbio-on-next-gen-immunotherapies/1130667.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/uk-gaining-pace-with-early-stage-trials-for-advanced-therapies/1130673.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ipsen-selects-pierrick-lefranc-as-new-evp-technical-operations/1130689.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/innovative-nanoparticle-research-could-restore-antibiotic-efficacy/1130697.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/dr-michael-j-miller-joins-sporebio-as-vp-of-scientific-and-regulatory-affairs/1130708.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/the-future-of-pharma-randd-leadership/1130720.article 2026-04-01T11:33:20.797Z https://www.europeanpharmaceuticalreview.com/news/fmt-shows-promise-for-enhancing-immunotherapy-effectiveness-in-advanced-cancer/1130733.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pharma-benefits-in-eu-india-free-trade-agreement/1130743.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/bioprocessing-symposium-to-showcase-biopharma-and-purification-innovation/1130791.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/roche-glp-1-produces-robust-weight-loss-in-late-stage-obesity-trial/1130797.article 2026-06-09T14:02:20.443Z https://www.europeanpharmaceuticalreview.com/from-quantum-to-clinic-ai-reshapes-clinical-trials/1130820.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/terpenes-in-medicinal-cannabis-a-formulation-challenge/1130833.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/moderna-and-recordati-collaborate-on-rare-disease-mrna-therapy/1130845.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/astrazeneca-makes-15bn-manufacturing-investment-in-china/1130860.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lilly-chooses-pennsylvania-for-35bn-injectables-manufacturing-facility/1130908.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sever-pharma-solutions-appoints-niklas-lindgren-as-vp-of-quality/1130914.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/dr-david-berman-to-join-moderna-as-chief-development-officer/1130923.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-launches-precheck-pilot-programme-for-us-pharma-manufacturers/1130953.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ardena-divests-södertälje-drug-substance-site-to-nanologica/1130955.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ucb-wins-chmp-favour-for-first-thymidine-kinase-2-deficiency-treatment/1130979.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/genentech-gains-rights-to-sanegenebios-rnai-pipeline-for-15bn/1131013.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/nmd-pharma-will-accelerate-rare-disease-drug-ignaseclant-despite-endpoint-miss/1131037.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/vetter-pharma-outlines-plans-for-new-manufacturing-site-in-germany/1131040.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/astrazenecas-imfinzi-plus-chemotherapy-earns-chmp-nod-in-gastric-cancer/1131078.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/crystallisation-research-could-enhance-api-drug-production/1131091.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gsks-nucala-green-lit-for-copd-in-expanded-eu-approval/1131105.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/titanium-dioxide-free-drotaverine-hydrochloride-tablets-developed/1131114.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/roches-fenebrutinib-demonstrates-decade-first-benefit-in-multiple-sclerosis/1131156.article 2026-06-09T13:51:31.427Z https://www.europeanpharmaceuticalreview.com/news/bms-partners-with-evinova-to-strengthen-clinical-development-using-ai/1131163.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lilly-acquires-car-t-therapy-biotech-orna-therapeutics-for-24bn/1131194.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ema-opens-consultation-for-annex-15-gmp-guidelines/1131201.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/webinars/smarter-raman-qc-for-biopharma-fill-finish-with-scalable-model-transfer/1131205.article 2026-06-05T16:01:57.347Z https://www.europeanpharmaceuticalreview.com/news/fresenius-kabi-and-phlow-onshore-us-epinephrine-manufacturing/1131209.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/precision-medicine-in-epilepsy-and-brain-health-as-a-strategic-investment/1131228.article 2026-04-28T13:01:13.877Z https://www.europeanpharmaceuticalreview.com/news/fujifilm-biotechnologies-inaugurates-expanded-400m-uk-biomanufacturing-site/1131245.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/dr-veit-bergendahl-to-join-rentschler-biopharma-as-chief-operating-officer/1131254.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/accelerating-consistent-stable-cell-line-development-with-targeted-integration/1131269.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/rottendorf-and-corealis-collaborate-on-osd-manufacturing/1131295.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sanofi-selects-dr-belen-garijo-as-new-ceo/1131297.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/formulation-research-offers-step-towards-digital-tablet-design/1131339.article 2026-04-24T14:16:46.197Z https://www.europeanpharmaceuticalreview.com/news/amgen-wins-new-european-approval-for-uplizna-in-generalised-myasthenia-gravis/1131367.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novartis-bolsters-the-case-for-vanrafias-full-approvals-in-iga-nephropathy/1131373.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sanofis-beyfortus-shows-infant-benefit-beyond-first-rsv-season/1131408.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/orsellinic-acid-produced-in-e-coli-for-first-time/1131414.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/rois-appoints-kimberlee-steele-as-chief-commercial-officer/1131424.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gsk-wins-dual-eu-approval-for-its-ultra-long-acting-biologic-exdensur/1131441.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pfizers-braftovi-improves-progression-free-survival-in-colorectal-cancer/1131467.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/recipharm-sells-manufacturing-site-to-scinai-in-biologics-collaboration/1131473.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/johnson-and-johnson-invests-1bn-in-us-cell-therapy-manufacturing/1131494.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-policy-sets-new-clinical-trial-requirements-for-drug-approvals/1131500.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/daiichi-sankyo-picks-dr-john-tsai-to-head-up-randd/1131523.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lillys-omvoh-demonstrates-long-term-potential-in-crohns/1131541.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/the-case-for-outsourcing-water-for-injection/1131549.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/leftover-bread-could-support-sustainable-pharmaceutical-manufacturing/1131585.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/eu-court-dismisses-pharma-call-to-annul-disputed-wastewater-rules/1131592.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gilead-adds-to-cell-therapy-portfolio-with-8bn-acquisition-of-arcellx/1131610.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-drafts-new-ultra-rare-disease-therapy-guidance/1131615.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/applying-ai-to-enhance-drug-formulation-and-development/1131637.article 2026-04-28T13:18:44.720Z https://www.europeanpharmaceuticalreview.com/news/abbvie-invests-380m-in-illinois-to-expand-us-api-manufacturing/1131650.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gsk-acquires-tgf-beta-protein-firm-35pharma-for-nearly-1bn/1131656.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novo-nordisk-strikes-21bn-oral-obesity-biologic-deal-with-vivtex/1131677.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novartis-to-site-fifth-radioligand-therapy-manufacturing-facility-in-texas/1131693.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lipid-nanoparticle-discovery-could-increase-drug-delivery-efficiency/1131707.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/charles-river-laboratories-parts-ways-with-its-cdmo-business/1131717.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novo-nordisk-expands-oral-glp-1-manufacturing-capacity-in-ireland/1131739.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/first-mrna-covid-19/flu-combination-vaccine-set-for-european-approval/1131745.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/blueprints-rare-disease-drug-ayvakit-shows-long-term-benefit/1131769.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/nanoparticle-ultrasound-combo-could-boost-drug-release-in-bacterial-biofilms/1131774.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ucb-signs-11bn-to-autoimmune-collaboration-with-chinese-biotech-antengene/1131810.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/optimising-efficiency-and-yield-through-bioprocessing-automation/1131814.article 2026-06-11T14:19:11.627Z https://www.europeanpharmaceuticalreview.com/news/novel-rapid-microbiological-detection-method-could-advance-surface-monitoring/1131820.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/reports/pharma-horizons-trends-in-pharmaceutical-manufacturing/1131835.article 2026-04-16T15:02:35.470Z https://www.europeanpharmaceuticalreview.com/the-implementation-of-biodiversity-footprinting-examining-supply-chains/1131839.article 2026-03-29T18:53:27.433Z https://www.europeanpharmaceuticalreview.com/news/sanofi-gains-access-to-first-in-class-jak-inhibitor-through-15bn-licensing-deal/1131912.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/enhanced-fluorescence-technique-optimises-bacterial-detection/1131926.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/biogen/stokes-zorevunersen-hailed-as-potential-first-disease-modifying-drug-for-rare-epilepsy/1131956.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/nanofiltration-study-highlights-next-generation-water-treatment-process/1131961.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/webinars/practical-steps-for-innovating-pharmaceutical-manufacturing/1131973.article 2026-06-17T07:31:05.910Z https://www.europeanpharmaceuticalreview.com/news/servier-deepens-rare-oncology-commitment-with-25bn-day-one-acquisition/1132030.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/cleanroom-air-quality-not-impaired-by-height-adjustable-furniture/1132041.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/neuland-laboratories-to-open-hyderabad-commercial-peptide-facility/1132047.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/csl-breaks-ground-on-15bn-illinois-plasma-therapy-facility-expansion/1132063.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/vinay-prasad-to-exit-cber-as-fda-group-director/1132075.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/fda-revises-pk-study-approach-in-new-biosimilar-draft-guidance/1132088.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/study-optimises-automated-de-bagging-in-aseptic-manufacturing/1132096.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gsk-grants-rare-disease-firm-alfasigma-rights-to-linerixibat-for-690m/1132114.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/chiesi-and-bespak-further-collaboration-to-advance-uk-production-of-low-carbon-inhalers/1132125.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/neuro-specialist-lundbeck-hires-new-ai-lead/1132172.article 2026-05-15T08:47:15.600Z https://www.europeanpharmaceuticalreview.com/optimising-the-downstream-process-in-lentiviral-vector-manufacturing/1132184.article 2026-06-18T15:28:28.993Z https://www.europeanpharmaceuticalreview.com/news/sanas-islet-cell-transplant-therapy-shows-early-promise-in-type-1-diabetes/1132217.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/eli-lilly-doubles-down-on-supply-chain-investment-in-asia/1132226.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/upcycled-plastic-could-facilitate-production-of-parkinsons-drug/1132294.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/sandoz-partners-with-samsung-bioepis-to-accelerate-biosimilar-pipeline/1132317.article 2026-06-17T10:22:55.827Z https://www.europeanpharmaceuticalreview.com/news/astrazenecas-imfinzi-wins-eu-first-immunotherapy-approval-in-early-gi-cancers/2134981.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/pennsylvania-to-house-new-actinium-225-manufacturing-facility/2135005.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/novartis-strengthens-its-breast-cancer-pipeline-with-3bn-synnovation-acquisition/2135007.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/bms-wins-dual-immunotherapy-first-approvals-in-classical-hodgkin-lymphoma/2135008.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/nanoparticle-exosome-innovation-could-enhance-cell-therapy-manufacturing/2135009.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/gilead-acquires-potential-first-in-class-t-cell-engager-in-2bn-deal-with-ouro-medicines/2135010.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ucb-positions-new-georgia-biologics-facility-as-future-us-manufacturing-hub/2135011.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/merck-expands-haematology-pipeline-with-67bn-acquisition-of-terns-pharmaceuticals/2135012.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/tmsi-a-novel-ai-driven-alternative-microbiological-method-for-microorganism-detection-enumeration-and-identification/2135013.article 2026-04-10T16:07:21.753Z https://www.europeanpharmaceuticalreview.com/news/novo-nordisks-awiqli-first-fda-approved-once-weekly-basal-insulin/2135030.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/holistic-automation-for-data-integrity-usability-and-sustainability/2135033.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/framework-supports-microbiota-assessment-in-cleanroom-changing-rooms/2135037.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/ucbs-tk2d-therapy-kygevvi-approved-by-european-commission/2135058.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/lilly-advances-neuroscience-portfolio-with-78bn-acquisition-of-centessa/2135091.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/news/editas-medicines-gene-edited-therapy-reni-cel-sees-early-clinical-success/2135113.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/mas-100-libra-automated-passive-air-sampling-without-air-flow-disturbance/2135121.article 2026-05-26T10:40:17.670Z https://www.europeanpharmaceuticalreview.com/smart-manufacturing-and-beyond-the-tri-integrity-and-the-support-to-quality-management-maturity-for-industry-40/2135123.article 2026-05-07T11:25:13.187Z https://www.europeanpharmaceuticalreview.com/news/fda-approves-lillys-small-molecule-obesity-pill-foundayo/2135125.article 2026-06-02T09:49:04.667Z https://www.europeanpharmaceuticalreview.com/trump-imposes-100-percent-tariff-on-imported-pharmaceuticals/2135126.article 2026-06-11T14:17:19.490Z https://www.europeanpharmaceuticalreview.com/from-what-is-it-to-what-does-it-mean/2135127.article 2026-04-14T16:37:58.403Z https://www.europeanpharmaceuticalreview.com/lipid-formulation-development-why-softgels-are-the-technology-of-choice/2135129.article 2026-06-05T09:17:47.220Z https://www.europeanpharmaceuticalreview.com/news/surface-bioburden-study-offers-insight-on-non-sterile-manufacturing/2135135.article 2026-04-24T14:11:32.673Z https://www.europeanpharmaceuticalreview.com/automating-ion-chromatography-for-reliable-routine-analysis/2135140.article 2026-06-12T14:36:42.437Z https://www.europeanpharmaceuticalreview.com/european-pharmaceutical-review-issue-1-2026-environmental-monitoring-in-depth-focus/2135141.article 2026-04-16T14:55:52.177Z https://www.europeanpharmaceuticalreview.com/european-pharmaceutical-review-issue-1-2026-drug-delivery-in-depth-focus/2135142.article 2026-06-05T11:58:43.463Z https://www.europeanpharmaceuticalreview.com/publications/european-pharmaceutical-review-issue-1-2026/2135145.article 2026-06-03T09:41:33.367Z https://www.europeanpharmaceuticalreview.com/news/gilead-strengthens-adc-capabilities-with-5bn-tubulis-acquisition/2135147.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/more-than-recombinant-its-recombinant-cascade/2135160.article 2026-04-23T11:10:54.573Z https://www.europeanpharmaceuticalreview.com/robust-high-throughput-automated-solution-for-water-endotoxin-testing/2135162.article 2026-04-14T16:37:56.560Z https://www.europeanpharmaceuticalreview.com/news/car-t-therapy-could-treat-severe-autoimmune-diseases-shows-study/2135165.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/raman-spectroscopy-market-reaches-235bn-driven-by-pharma/2135172.article 2026-04-24T14:58:24.873Z https://www.europeanpharmaceuticalreview.com/news/analytical-framework-demonstrates-potential-in-single-use-chromatographic-purification/2135184.article 2026-04-24T14:08:01.970Z https://www.europeanpharmaceuticalreview.com/scaling-complex-cell-therapies-from-clinical-to-commercial--references/2135187.article 2026-04-10T20:32:36.503Z https://www.europeanpharmaceuticalreview.com/accelerating-consistent-stable-cell-line-development-with-targeted-integration-references/2135189.article 2026-04-10T20:32:00.723Z https://www.europeanpharmaceuticalreview.com/lipid-formulation-development-why-softgels-are-the-technology-of-choice-references/2135191.article 2026-04-10T20:31:33.393Z https://www.europeanpharmaceuticalreview.com/ich-q3c-residual-solvents-references/2135197.article 2026-04-13T09:58:40.160Z https://www.europeanpharmaceuticalreview.com/news/european-commission-expands-dupixent-approval-in-chronic-spontaneous-urticaria/2135199.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/regeneron-and-telix-collaborate-to-advance-biologics-based-radiopharmaceuticals/2135208.article 2026-06-11T14:15:06.770Z https://www.europeanpharmaceuticalreview.com/webinars/enhancing-laboratory-workflows-with-qpcr-automation/2135212.article 2026-06-29T07:15:16.570Z https://www.europeanpharmaceuticalreview.com/news/new-fda-draft-guidance-to-enhance-safety-of-genome-editing-therapies/2135215.article 2026-04-17T16:46:11.077Z https://www.europeanpharmaceuticalreview.com/news/food-grade-materials-potential-alternative-for-one-dose-pharmaceutical-packaging/2135227.article 2026-04-17T09:26:09.673Z https://www.europeanpharmaceuticalreview.com/fujifilm-biotechnologies-opens-new-qc-lab-in-denmark/2135238.article 2026-04-17T11:00:33.913Z https://www.europeanpharmaceuticalreview.com/how-to-choose-the-right-microbial-air-sampler/2135239.article 2026-04-23T07:57:25.823Z https://www.europeanpharmaceuticalreview.com/ucb-expands-into-regenerative-cell-therapy-through-115bn-neurona-acquisition/2135245.article 2026-04-20T10:56:47.220Z https://www.europeanpharmaceuticalreview.com/digital-framework-could-optimise-pharmaceutical-wastewater-treatment-design/2135259.article 2026-04-24T15:12:01.957Z https://www.europeanpharmaceuticalreview.com/manufacturing-data-innovation-set-to-accelerate-medicine-development/2135263.article 2026-04-24T15:10:05.693Z https://www.europeanpharmaceuticalreview.com/news/abbvie-expands-us-footprint-with-new-14-billion-manufacturing-campus/2135272.article 2026-04-27T08:25:54.403Z https://www.europeanpharmaceuticalreview.com/news/multina-ii-mce-301-smarter-nucleic-acid-analysis-for-the-modern-lab/2135276.article 2026-04-30T13:50:09.553Z https://www.europeanpharmaceuticalreview.com/main-navigation/choosing-the-right-crystal-solid-form-optimisation-for-pharmaceutical-development/2135277.article 2026-06-26T08:37:15.630Z https://www.europeanpharmaceuticalreview.com/amgens-chief-technology-officer-dr-david-reese-to-retire/2135288.article 2026-04-24T09:52:57.640Z https://www.europeanpharmaceuticalreview.com/otarmeni-regenerons-first-genetic-medicine-to-gain-approval/2135302.article 2026-04-27T13:11:37.163Z https://www.europeanpharmaceuticalreview.com/the-bayesian-edge-how-the-new-fda-guidance-is-enabling-nimble-efficient-clinical-trials/2135307.article 2026-04-27T14:00:48.460Z https://www.europeanpharmaceuticalreview.com/lilly-adds-potential-first-in-class-type-ii-jak2-inhibitor-to-haematology-portfolio/2135318.article 2026-04-28T10:04:43.980Z https://www.europeanpharmaceuticalreview.com/process-raman-spectroscopy-closing-biomanufacturings-measurement-infrastructure-gap/2135324.article 2026-04-28T11:49:54.953Z https://www.europeanpharmaceuticalreview.com/real-time-raman-spectroscopy-closes-bioprocess-control-measurement-gap/2135326.article 2026-05-13T14:35:52.837Z https://www.europeanpharmaceuticalreview.com/news/fda-approves-breztri-as-first-triple-therapy-inhaler-for-asthma/2135327.article 2026-04-28T13:23:46.783Z https://www.europeanpharmaceuticalreview.com/the-shift-towards-strategic-adoption-of-intelligent-automation-in-pharmaceutical-microbiology/2135328.article 2026-06-18T15:21:25.987Z https://www.europeanpharmaceuticalreview.com/boehringers-glp-1-dual-agonist-survodutide-shines-in-phase-iii-trial/2135336.article 2026-04-29T12:39:36.973Z https://www.europeanpharmaceuticalreview.com/cphi-americas-2026-returns-to-philadelphia-with-ai-regulatory-focus/2135351.article 2026-05-29T08:16:02.427Z https://www.europeanpharmaceuticalreview.com/advancing-next-generation-integrase-inhibitors-for-hiv/2135359.article 2026-04-30T13:08:38.500Z https://www.europeanpharmaceuticalreview.com/bioplastic-produced-from-hemp-waste-potential-eco-alternative-for-packaging-films/2135366.article 2026-05-21T11:36:26.940Z https://www.europeanpharmaceuticalreview.com/fda-marks-progress-in-implementing-real-time-clinical-trials/2135372.article 2026-05-21T11:24:44.687Z https://www.europeanpharmaceuticalreview.com/novartis-to-site-seventh-new-facility-in-north-carolina/2135376.article 2026-05-21T11:20:00.170Z https://www.europeanpharmaceuticalreview.com/amgen-invests-additional-300m-to-strengthen-biomanufacturing-in-puerto-rico/2135382.article 2026-05-21T11:16:23.057Z https://www.europeanpharmaceuticalreview.com/new-ocabr-vaccine-guidelines-to-improve-regulation-efficiency/2135400.article 2026-05-21T11:04:32.520Z https://www.europeanpharmaceuticalreview.com/fda-refines-strategy-with-one-day-inspectional-assessment-pilot/2135409.article 2026-05-14T11:31:26.747Z https://www.europeanpharmaceuticalreview.com/reports/pharma-horizons-cell-and-gene-therapy/2135415.article 2026-06-30T10:42:22.460Z https://www.europeanpharmaceuticalreview.com/mhra-proposes-modernisation-of-gene-therapy-products-classification/2135424.article 2026-05-14T11:40:02.560Z https://www.europeanpharmaceuticalreview.com/ai-to-accelerate-novo-nordisks-parkinsons-cell-therapy/2135436.article 2026-05-14T11:36:32.570Z https://www.europeanpharmaceuticalreview.com/study-explores-nanoparticle-approach-to-pharmaceutical-wastewater-pollution/2135441.article 2026-05-14T11:33:18.320Z https://www.europeanpharmaceuticalreview.com/adopting-an-ai-driven-approach-to-scale-with-confidence/2135444.article 2026-05-15T13:26:28.420Z https://www.europeanpharmaceuticalreview.com/news/from-endotoxins-to-ai-what-to-expect-at-the-future-of-bio/pharmaceutical-analysis-2026/2135451.article 2026-05-14T12:01:30.740Z https://www.europeanpharmaceuticalreview.com/makary-resigns-as-commissioner-of-us-fda/2135458.article 2026-05-15T13:10:14.397Z https://www.europeanpharmaceuticalreview.com/eu-commission-agree-to-move-critical-medicines-act-towards-approval/2135471.article 2026-05-15T11:57:39.973Z https://www.europeanpharmaceuticalreview.com/krystal-biotech-wins-mhra-approval-for-genetic-medicine-vyjuvek/2135475.article 2026-05-18T13:08:40.343Z https://www.europeanpharmaceuticalreview.com/shionogi-ranks-second-in-2026-antimicrobial-resistance-benchmark-report/2135491.article 2026-05-22T09:54:48.810Z https://www.europeanpharmaceuticalreview.com/novel-bioprocessing-technology-demonstrates-one-step-continuous-operation/2135494.article 2026-05-19T14:28:05.710Z https://www.europeanpharmaceuticalreview.com/news/fda-approves-first-in-class-aldosterone-synthase-inhibitor-for-uncontrolled-hypertension/2135500.article 2026-05-29T11:47:34.790Z https://www.europeanpharmaceuticalreview.com/fujifilm-cellular-dynamics-opens-new-us-ipsc-facility/2135501.article 2026-05-20T10:29:59.090Z https://www.europeanpharmaceuticalreview.com/news/day-one-in-focus-rethinking-qa/qc-at-the-future-of-bio/pharmaceutical-analysis-2026/2135510.article 2026-05-28T08:59:31.803Z https://www.europeanpharmaceuticalreview.com/mhra-opens-consultation-for-landmark-rare-disease-therapy-draft-guidance/2135516.article 2026-05-21T11:00:42.857Z https://www.europeanpharmaceuticalreview.com/optimised-semaglutide-formulation-could-advance-peptide-based-oral-delivery/2135528.article 2026-06-02T09:26:01.087Z https://www.europeanpharmaceuticalreview.com/medicines-as-strategic-assets-the-new-politics-of-pharma-supply/2135530.article 2026-06-11T14:38:41.847Z https://www.europeanpharmaceuticalreview.com/macrophage-cell-therapy-signals-advancement-in-regenerative-medicine/2135532.article 2026-06-11T14:35:13.273Z https://www.europeanpharmaceuticalreview.com/bioprocessing-and-biomanufacturing/enhancing-downstream-processing-for-biologic-therapies/2135534.article 2026-06-29T08:28:38.730Z https://www.europeanpharmaceuticalreview.com/pharming-secures-novel-eu-approval-for-joenja-in-activated-pi3k-delta-syndrome/2135541.article 2026-05-26T10:56:09.387Z https://www.europeanpharmaceuticalreview.com/whats-changing-in-ai-regulation-for-drug-development/2135546.article 2026-06-11T13:59:54.937Z https://www.europeanpharmaceuticalreview.com/selecting-the-right-qpcr-workflow-strategy-task-based-vs-full-automation/2135547.article 2026-06-01T08:25:05.963Z https://www.europeanpharmaceuticalreview.com/thermal-assurance-as-an-operating-model-why-the-pharmaceutical-cold-chain-must-evolve-beyond-visibility/2135561.article 2026-05-28T08:30:06.513Z https://www.europeanpharmaceuticalreview.com/eli-lilly-bolsters-infectious-disease-portfolio-with-acquisitions-totalling-38bn/2135567.article 2026-05-28T09:17:05.880Z https://www.europeanpharmaceuticalreview.com/day-two-in-focus-navigating-regulatory-strategy-at-the-future-of-bio/pharmaceutical-analysis-2026/2135570.article 2026-05-28T10:14:44.923Z https://www.europeanpharmaceuticalreview.com/novel-car-t-manufacturing-process-significantly-cuts-production-time/2135575.article 2026-05-28T14:28:36.890Z https://www.europeanpharmaceuticalreview.com/pfizer-partners-with-innovent-for-105bn-to-advance-adc-oncology-medicines/2135584.article 2026-06-11T14:33:13.357Z https://www.europeanpharmaceuticalreview.com/idorsias-glycan-targeting-c-diff-vaccine-maintains-positive-clinical-trajectory/2135603.article 2026-06-01T10:49:30.467Z https://www.europeanpharmaceuticalreview.com/implementing-horizontal-recycling-for-pharmaceutical-release-liners/2135605.article 2026-06-23T15:30:18.403Z https://www.europeanpharmaceuticalreview.com/lilly-licenses-hanmis-glp-2-biologic-sonefpeglutide-for-12bn/2135614.article 2026-06-02T12:19:08.137Z https://www.europeanpharmaceuticalreview.com/biologics-growth-expected-to-reshape-pharmaceutical-packaging-demand/2135615.article 2026-06-02T13:36:55.500Z https://www.europeanpharmaceuticalreview.com/breaking-the-biomanufacturing-mould-a-patient-centric-cdmo-approach/2135618.article 2026-06-02T15:15:00.233Z https://www.europeanpharmaceuticalreview.com/news/eu-commission-issues-plan-to-replace-animal-testing-in-chemical-safety-assessments/2135621.article 2026-06-11T14:32:22.413Z https://www.europeanpharmaceuticalreview.com/day-three-preview-the-future-of-bio/pharma-analysis-virtual-summit-2026/2135631.article 2026-06-26T08:35:05.073Z https://www.europeanpharmaceuticalreview.com/correctsequences-base-editing-therapy-shows-preliminary-success-in-sickle-cell-disease/2135634.article 2026-06-12T08:23:40.837Z https://www.europeanpharmaceuticalreview.com/amgens-imdylltra-approved-in-europe-for-aggressive-solid-tumour/2135642.article 2026-06-12T08:22:53.623Z https://www.europeanpharmaceuticalreview.com/staying-competitive-within-the-evolving-cdmo-model/2135643.article 2026-06-30T11:56:56.760Z https://www.europeanpharmaceuticalreview.com/roche-and-nurix-to-advance-potential-best-in-class-btk-degrader-bexobrutideg/2135655.article 2026-06-12T08:24:15.703Z https://www.europeanpharmaceuticalreview.com/formulation-and-drug-delivery/gilead-msd-once-weekly-oral-hiv-regimen-meets-phase-iii-endpoints/2135674.article 2026-06-09T15:15:00.080Z https://www.europeanpharmaceuticalreview.com/news/gsk-advances-oncology-efforts-with-106bn-nuvalent-acquisition/2135683.article 2026-06-12T08:22:05.850Z https://www.europeanpharmaceuticalreview.com/what-annex-22-spells-for-ai-in-gmp-manufacturing/2135686.article 2026-06-15T08:49:31.090Z https://www.europeanpharmaceuticalreview.com/mhra-targets-medicine-safety-with-new-ai-sandbox/2135692.article 2026-06-11T13:55:29.837Z https://www.europeanpharmaceuticalreview.com/petri-dish-study-could-enhance-accuracy-of-microbiological-testing/2135709.article 2026-06-12T11:24:08.680Z https://www.europeanpharmaceuticalreview.com/mhra-green-lights-lower-dose-eurneffy-nasal-spray-for-children/2135714.article 2026-06-15T10:49:37.400Z https://www.europeanpharmaceuticalreview.com/recipharm-makes-major-investment-to-expand-us-sterile-manufacturing-footprint/2135726.article 2026-06-16T10:59:20.463Z https://www.europeanpharmaceuticalreview.com/sandoz-prepares-for-biosimilar-golden-decade-with-new-development-centre-in-slovenia/2135733.article 2026-06-17T11:08:57.300Z https://www.europeanpharmaceuticalreview.com/fap-targeted-radiopharmaceuticals-potential-as-next-gen-treatment-for-multiple-cancers/2135750.article 2026-06-18T11:44:29.760Z https://www.europeanpharmaceuticalreview.com/troubleshooting-capping-defects-in-brittle-tablet-formulations/2135751.article 2026-06-22T13:25:41.850Z https://www.europeanpharmaceuticalreview.com/news/improving-patient-centricity-with-advanced-polymer-excipients/2135753.article 2026-06-29T07:20:21.233Z https://www.europeanpharmaceuticalreview.com/biogen-acquires-immunology-start-up-raythera-for-1bn/2135758.article 2026-06-19T11:12:09.653Z https://www.europeanpharmaceuticalreview.com/paulo-fontoura-to-lead-research-and-development-at-sanofi/2135774.article 2026-06-22T11:22:09.687Z https://www.europeanpharmaceuticalreview.com/closing-the-last-mile-the-key-to-fully-unlocking-healthcare-value-in-europe/2135781.article 2026-06-26T08:35:36.840Z https://www.europeanpharmaceuticalreview.com/carsgen-wins-first-global-approval-of-car-t-therapy-for-solid-tumours/2135788.article 2026-06-24T09:33:30.700Z https://www.europeanpharmaceuticalreview.com/reports/pharma-horizons-process-analytical-technology-pat/2135794.article 2026-06-30T15:49:00.090Z https://www.europeanpharmaceuticalreview.com/edqm-removes-rabbit-pyrogen-test-references-in-revised-ocabr-guidelines/2135799.article 2026-06-24T11:17:56.093Z https://www.europeanpharmaceuticalreview.com/implementing-reporter-assay-based-mat-for-rapid-pyrogen-detection/2135806.article 2026-06-30T08:58:04.520Z https://www.europeanpharmaceuticalreview.com/novartis-and-antares-target-undruggable-oncology-in-18bn-deal/2135810.article 2026-06-25T11:46:02.793Z https://www.europeanpharmaceuticalreview.com/genentechs-xofluza-approved-as-first-single-dose-generic-for-influenza-in-us/2135824.article 2026-06-26T13:11:21.983Z https://www.europeanpharmaceuticalreview.com/predictive-stability-modelling-promising-tool-for-optimising-moisture-sensitive-formulations/2135830.article 2026-06-29T11:57:18.860Z https://www.europeanpharmaceuticalreview.com/simplified-c-glycosides-synthesis-could-transform-diabetes-drug-manufacturing/2135839.article 2026-06-30T13:15:21.657Z